Live Breaking News & Updates on Rafael Amado|Page 6

Stay updated with breaking news from Rafael amado. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Allogene Therapeutics, Inc. (NASDAQ:ALLO) to Post FY2022 Earnings of ($2.43) Per Share, Oppenheimer Forecasts

Allogene Therapeutics, Inc. (NASDAQ:ALLO – Get Rating) – Equities researchers at Oppenheimer increased their FY2022 earnings per share estimates for shares of Allogene Therapeutics in a report released on Tuesday, August 9th. Oppenheimer analyst M. Breidenbach now expects that the company will earn ($2.43) per share for the year, up from their previous forecast of […] ....

Raymond James , Owenn Witte , Rafael Amado , Robertw Baird , Primecap Management Co , Securities Exchange Commission , Allogene Therapeutics Inc , Goldman Sachs Group Inc , Blackrock Inc , Jpmorgan Chase Co , Goldman Sachs Group , Allogene Therapeutics , Get Rating , Allogene Therapeutic , Exchange Commission , Director Owen , Street Corp , Sachs Group , Nasdaq Allo , Earnings Estimates , Oppenheimer Holdings Inc ,